Supplementeray table II- Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort. Vanlerberghe et al

Supplementary table II : number and reasons of JAK inhibitor discontinuation补充表II：JAK抑制剂（JAK inhibitor）停药的例数及原因